| Literature DB >> 35508655 |
Thomas Hennig1, Archana B Prusty2, Benedikt B Kaufer3, Adam W Whisnant1, Manivel Lodha1, Antje Enders1, Julius Thomas1, Francesca Kasimir1, Arnhild Grothey1, Teresa Klein4, Stefanie Herb1, Christopher Jürges1, Markus Sauer4,5, Utz Fischer2,6, Thomas Rudel6,7, Gunter Meister8, Florian Erhard1, Lars Dölken9,10, Bhupesh K Prusty11,12.
Abstract
Herpesviruses have mastered host cell modulation and immune evasion to augment productive infection, life-long latency and reactivation1,2. A long appreciated, yet undefined relationship exists between the lytic-latent switch and viral non-coding RNAs3,4. Here we identify viral microRNA (miRNA)-mediated inhibition of host miRNA processing as a cellular mechanism that human herpesvirus 6A (HHV-6A) exploits to disrupt mitochondrial architecture, evade intrinsic host defences and drive the switch from latent to lytic virus infection. We demonstrate that virus-encoded miR-aU14 selectively inhibits the processing of multiple miR-30 family members by direct interaction with the respective primary (pri)-miRNA hairpin loops. Subsequent loss of miR-30 and activation of the miR-30-p53-DRP1 axis triggers a profound disruption of mitochondrial architecture. This impairs induction of type I interferons and is necessary for both productive infection and virus reactivation. Ectopic expression of miR-aU14 triggered virus reactivation from latency, identifying viral miR-aU14 as a readily druggable master regulator of the herpesvirus lytic-latent switch. Our results show that miRNA-mediated inhibition of miRNA processing represents a generalized cellular mechanism that can be exploited to selectively target individual members of miRNA families. We anticipate that targeting miR-aU14 will provide new therapeutic options for preventing herpesvirus reactivations in HHV-6-associated disorders.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35508655 DOI: 10.1038/s41586-022-04667-4
Source DB: PubMed Journal: Nature ISSN: 0028-0836 Impact factor: 49.962